{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T23:32:23Z","timestamp":1773963143318,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00210-025-04158-z","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T05:52:26Z","timestamp":1744696346000},"page":"13903-13906","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Amlodipine with letrozole as maintenance post-chemotherapy: targeting calcium calcineurin calmodulin pathway and aromatase inhibitor in disseminated endometrioid adenocarcinoma of the endometrium\u2014a case report"],"prefix":"10.1007","volume":"398","author":[{"given":"Mukul Arvind","family":"Gharote","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amruta Ashok","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amogh Satchidanand","family":"Kale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"issue":"3","key":"4158_CR1","first-page":"212","volume":"47","author":"XX Bao","year":"2012","unstructured":"Bao XX, Wang JL, Wei LH (2012) Impact of calcium channel antagonists for estrogen action on the endometrial carcinoma HEC-1A cells. Zhonghua Fu Chan Ke Za Zhi 47(3):212\u2013217","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"2","key":"4158_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0171-2985(00)80060-1","volume":"202","author":"S Feske","year":"2000","unstructured":"Feske S, Draeger R, Peter HH, Rao A (2000) Impaired NFAT regulation and its role in a severe combined immunodeficiency. Immunobiology 202(2):134\u2013150. https:\/\/doi.org\/10.1016\/S0171-2985(00)80060-1","journal-title":"Immunobiology"},{"issue":"4","key":"4158_CR3","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/86318","volume":"2","author":"S Feske","year":"2001","unstructured":"Feske S, Giltnane J, Dolmetsch R, Staudt LM, Rao A (2001) Gene regulation mediated by calcium signals in T lymphocytes. Nat Immunol. 2(4):316\u201324. https:\/\/doi.org\/10.1038\/86318. Erratum in: Nat Immunol. 2008 Mar;9(3):328-9","journal-title":"Nat Immunol."},{"issue":"3","key":"4158_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.25259\/IJMIO_13_2021","volume":"6","author":"MA Gharote","year":"2021","unstructured":"Gharote MA (2021) Amlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitor. Int J Mol Immuno Oncol 6(3):145\u2013148","journal-title":"Int J Mol Immuno Oncol"},{"issue":"3","key":"4158_CR5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1161\/CIRCRESAHA.117.310183","volume":"121","author":"A Ghigo","year":"2017","unstructured":"Ghigo A, Laffargue M, Li M, Hirsch E (2017) PI3K and calcium signaling in cardiovascular disease. Circ Res 121(3):282\u2013292. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.310183","journal-title":"Circ Res"},{"issue":"3","key":"4158_CR6","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.7150\/ijbs.68591","volume":"18","author":"T Huang","year":"2022","unstructured":"Huang T, Zhou J, Wang J (2022) Calcium and calcium-related proteins in endometrial cancer: opportunities for pharmacological intervention. Int J Biol Sci 18(3):1065\u20131078. https:\/\/doi.org\/10.7150\/ijbs.68591","journal-title":"Int J Biol Sci"},{"key":"4158_CR7","doi-asserted-by":"publisher","first-page":"101682","DOI":"10.1016\/j.nantod.2022.101682","volume":"47","author":"T Huang","year":"2022","unstructured":"Huang T, Zhou J, Zhang L, Yang X, Cheng Y, Yin S et al (2022) Azelnidipine nanoparticles break calcium homeostasis and induce severe ER stress combined with medroxyprogesterone acetate for endometrial cancer therapy. Nano Today 47:101682. https:\/\/doi.org\/10.1016\/j.nantod.2022.101682. (ISSN 1748-0132)","journal-title":"Nano Today"},{"issue":"18","key":"4158_CR8","doi-asserted-by":"publisher","first-page":"9918","DOI":"10.3390\/ijms25189918","volume":"25","author":"G Hunek","year":"2024","unstructured":"Hunek G, Zembala J, Januszewski J, Be\u0142\u017cek A, Syty K, Jabiry-Zieniewicz Z et al (2024) Micro- and macronutrients in endometrial cancer-from metallomic analysis to improvements in treatment strategies. Int J Mol Sci 25(18):9918. https:\/\/doi.org\/10.3390\/ijms25189918","journal-title":"Int J Mol Sci"},{"key":"4158_CR9","doi-asserted-by":"publisher","first-page":"13297","DOI":"10.1038\/ncomms13297","volume":"7","author":"G Jacquemet","year":"2016","unstructured":"Jacquemet G, Baghirov H, Georgiadou M et al (2016) L-type calcium channels regulate filopodia stability and cancer cell invasion downstream of integrin signalling. Nat Commun 7:13297. https:\/\/doi.org\/10.1038\/ncomms13297","journal-title":"Nat Commun"},{"issue":"6","key":"4158_CR10","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/s41388-020-01592-6","volume":"40","author":"C Li","year":"2021","unstructured":"Li C, Yao H, Wang H, Fang JY, Xu J (2021) Repurposing screen identifies Amlodipine as an inducer of PD-L1 degradation and antitumor immunity. Oncogene 40(6):1128\u20131146. https:\/\/doi.org\/10.1038\/s41388-020-01592-6","journal-title":"Oncogene"},{"issue":"1","key":"4158_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10147-006-0619-9","volume":"12","author":"AA Secord","year":"2007","unstructured":"Secord AA, Havrilesky LJ, Carney ME, Soper JT, Clarke-Pearson DL, Rodriguez GC, Berchuck A (2007) Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer. Int J Clin Oncol 12(1):31\u201336. https:\/\/doi.org\/10.1007\/s10147-006-0619-9","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"4158_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/ajh.2007.13","volume":"21","author":"E Shima","year":"2008","unstructured":"Shima E, Katsube M, Kato T, Kitagawa M, Hato F, Hino M et al (2008) Calcium channel blockers suppress cytokine-induced activation of human neutrophils. Am J Hypertens 21(1):78\u201384. https:\/\/doi.org\/10.1038\/ajh.2007.13","journal-title":"Am J Hypertens"},{"issue":"8","key":"4158_CR13","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1200\/JCO.2014.58.3401","volume":"33","author":"BM Slomovitz","year":"2015","unstructured":"Slomovitz BM, Jiang Y, Yates MS, Soliman PT, Johnston T, Nowakowski M et al (2015) Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma. J Clin Oncol. 33(8):930\u20136. https:\/\/doi.org\/10.1200\/JCO.2014.58.3401","journal-title":"J Clin Oncol."},{"issue":"4","key":"4158_CR14","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/IGC.0b013e31824a3385","volume":"22","author":"I Vandenput","year":"2012","unstructured":"Vandenput I, Vergote I, Neven P, Amant F (2012) Weekly paclitaxel-carboplatin regimen in patients with primary advanced or recurrent endometrial carcinoma. Int J Gynecol Cancer 22(4):617\u2013622. https:\/\/doi.org\/10.1097\/IGC.0b013e31824a3385","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"4158_CR15","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.3390\/cancers15061799","volume":"15","author":"VM Wagner","year":"2023","unstructured":"Wagner VM, Backes FJ (2023) Do not forget about hormonal therapy for recurrent endometrial cancer: a review of options, updates, and new combinations. Cancers (Basel) 15(6):1799. https:\/\/doi.org\/10.3390\/cancers15061799","journal-title":"Cancers (Basel)"},{"issue":"4","key":"4158_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/onc.2012.76","volume":"32","author":"A Yeramian","year":"2013","unstructured":"Yeramian A, Moreno-Bueno G, Dolcet X, Catasus L, Abal M, Colas E, Reventos J et al (2013) Endometrial carcinoma: molecular alterations involved in tumor development and progression. Oncogene 32(4):403\u2013413. https:\/\/doi.org\/10.1038\/onc.2012.76","journal-title":"Oncogene"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04158-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04158-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04158-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T04:12:06Z","timestamp":1759983126000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04158-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["4158"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04158-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}